ÂÜÀòÂÒÂ×

Franjo Hanzl has extensive experience in the pharmaceutical and biotech industries, with a focus on commercial development, alliance management, and global markets. Franjo has held various leadership roles throughout their career, including Vice President positions at Cencora and EVERSANA, where they were responsible for client relations and commercial development in Europe. Before that, they worked at Orexigen Therapeutics, where they served as Vice President of Global Alliance Management, Commercial Director for European Markets, Managing Director for the UK and Ireland, and Senior Director of Global Alliance Management. Prior to Orexigen Therapeutics, Franjo held roles at Adamed, Jadran Galenski laboratorij d.d., Merck, MSD Sharp & Dohme GmbH, Schering Plough, Nycomed, and sanofi-aventis.

Franjo Hanzl obtained a Master's degree in Pharmacy from Sveuciliste u Zagrebu from 1990 to 1997. Additionally, they pursued a course in Pharmacy at the same university from 1991 to 1996. In the years 1987 to 1991, Hanzl attended Kemijsko-tehnološki obrazovni centar, but no specific degree or field of study is mentioned. Finally, Hanzl obtained a degree of Mr.pharm. in Pharmacy from Sveuciliste u Zagrebu.